Steris (STE) Income from Continuing Operations (2018 - 2026)
Steris (STE) recorded quarterly Income from Continuing Operations of 220300000.0 in Q1 2026, up 13.38% quarter-over-quarter from 194300000.0 in Q4 2025, and up 50.07% on a YoY basis from 146800000.0 in Q1 2025.
Steris (STE) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Steris' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 220300000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 50.07% year-over-year to 220300000.0; the TTM figure through Mar 2026 stood at 785100000.0 (up 28.41% YoY), while the FY2026 annual figure was 785100000.0, up 28.39% from the prior year.
- Income from Continuing Operations was 220300000.0 for Q1 2026 at Steris, up from 194300000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 220300000.0 in Q1 2026 to a low of 93642000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 152918764.71 across 5 years, with a median of 148603000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations soared 643.72% in 2022, then retreated 15.86% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 131005000.0 in 2022, then climbed by 13.43% to 148603000.0 in 2023, then gained by 16.62% to 173300000.0 in 2024, then increased by 12.12% to 194300000.0 in 2025, then grew by 13.38% to 220300000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 220300000.0 (Q1 2026), 194300000.0 (Q4 2025), and 192500000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220.30 Mn |
| Dec 31, 2025 | 194.30 Mn |
| Sep 30, 2025 | 192.50 Mn |
| Jun 30, 2025 | 178.00 Mn |
| Mar 31, 2025 | 146.80 Mn |
| Dec 31, 2024 | 173.30 Mn |
| Sep 30, 2024 | 151.40 Mn |
| Jun 30, 2024 | 139.90 Mn |
| Mar 31, 2024 | 153.30 Mn |
| Dec 31, 2023 | 148.60 Mn |
| Sep 30, 2023 | 120.80 Mn |
| Jun 30, 2023 | 130.58 Mn |
| Mar 31, 2023 | 182.20 Mn |
| Dec 31, 2022 | 131.01 Mn |
| Sep 30, 2022 | 123.91 Mn |
| Jun 30, 2022 | 119.09 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 143.09 Mn |
| Sep 30, 2021 | 69.63 Mn |
| Jun 30, 2021 | -21.90 Mn |